Transforming growth factor-beta(TGF-β)type II receptor(TβRII)levels are extremely low in the brain tissue of patients with Alzheimer’s disease.This receptor
<正>The article by Meves and Zheng(2014)is addressing a continuous shift in the field of spinal cord injury(SCI)research that has occurred over the last century
<正>Currently,we know that neuronal outgrowth during development and regeneration requires a complex interaction of intra-and extracellular molecules such as gr